GSK plc announced that on March 4, 2026, it purchased 550,000 shares at prices between 2,109p and 2,149p as part of its ongoing buyback program, totaling 5,816,000 shares since February 17, 2026. Following this purchase, GSK holds 245,707,094 shares in treasury from a total of 4,070,455,394 shares outstanding, reflecting a voting rights percentage of 6.04%.